Stemnovate’s compliant organs-on-chip platforms integrate stem cell research and tissue engineering to provide physiological alternative to cancer lines and animal models for precision drug discovery and screening.
| Status | Active |
| Website | https://stemnovate.co.uk/ |
| Category | Pharmaceutical Enabler |
| Modality | Cell |
| Headquarters | Cambridge, UK |
| Investment Portfolio | Pre-Fund Investment |
| Co-Investors | Business Angels, Innovate UK |